Global Anti-Tumor Drugs Market Research Report 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 96

Report ID: 6362

Tumor is also termed as neoplasm and it is caused by an abnormal proliferation of tissues. This abnormal proliferation can be due to genetic mutations. Tumors can be subcategorized as benign and malignant. Benign is not destructive however, possess a potential to turn into a malignant tumor... It has been observed that cancer is second leading cause of deaths in Europe and North America. To treat these tumor growth, anti tumor drugs are considered as of one of the key therapy which has been accepted worldwide.
The market is concentrated in the North American region and together with Europe accounts for over 60% of the market share. The Asian and African economies possess a substantial growth opportunity owing to high cancer mortalities and bleak availability of effective drugs. Chinese and Japanese drug manufacturers dominate the Asian market with over 60% of the regional share.

The global Anti-Tumor Drugs market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Anti-Tumor Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Anti-Tumor Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Roche
Novartis
Celgene
...

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Surgical
Chemotherapy
Radiation
Targeted
Immunotherapy

Segment by Application
Hospital Use
Clinic Use
Household
Other

Table of Contents

Executive Summary
1 Anti-Tumor Drugs Market Overview
1.1 Product Overview and Scope of Anti-Tumor Drugs
1.2 Anti-Tumor Drugs Segment by Type
1.2.1 Global Anti-Tumor Drugs Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Surgical
1.2.3 Chemotherapy
1.2.4 Radiation
1.2.5 Targeted
1.2.6 Immunotherapy
1.3 Anti-Tumor Drugs Segment by Application
1.3.1 Anti-Tumor Drugs Consumption Comparison by Application (2014-2025)
1.3.2 Hospital Use
1.3.3 Clinic Use
1.3.4 Household
1.3.5 Other
1.4 Global Anti-Tumor Drugs Market by Region
1.4.1 Global Anti-Tumor Drugs Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Anti-Tumor Drugs Market Size
1.5.1 Global Anti-Tumor Drugs Revenue (2014-2025)
1.5.2 Global Anti-Tumor Drugs Production (2014-2025)

2 Global Anti-Tumor Drugs Market Competition by Manufacturers
2.1 Global Anti-Tumor Drugs Production Market Share by Manufacturers (2014-2019)
2.2 Global Anti-Tumor Drugs Revenue Share by Manufacturers (2014-2019)
2.3 Global Anti-Tumor Drugs Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Anti-Tumor Drugs Production Sites, Area Served, Product Types
2.5 Anti-Tumor Drugs Market Competitive Situation and Trends
2.5.1 Anti-Tumor Drugs Market Concentration Rate
2.5.2 Anti-Tumor Drugs Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Anti-Tumor Drugs Production Market Share by Regions
3.1 Global Anti-Tumor Drugs Production Market Share by Regions
3.2 Global Anti-Tumor Drugs Revenue Market Share by Regions (2014-2019)
3.3 Global Anti-Tumor Drugs Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Anti-Tumor Drugs Production
3.4.1 North America Anti-Tumor Drugs Production Growth Rate (2014-2019)
3.4.2 North America Anti-Tumor Drugs Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Anti-Tumor Drugs Production
3.5.1 Europe Anti-Tumor Drugs Production Growth Rate (2014-2019)
3.5.2 Europe Anti-Tumor Drugs Production, Revenue, Price and Gross Margin (2014-2019)
3.6 China Anti-Tumor Drugs Production (2014-2019)
3.6.1 China Anti-Tumor Drugs Production Growth Rate (2014-2019)
3.6.2 China Anti-Tumor Drugs Production, Revenue, Price and Gross Margin (2014-2019)
3.7 Japan Anti-Tumor Drugs Production (2014-2019)
3.7.1 Japan Anti-Tumor Drugs Production Growth Rate (2014-2019)
3.7.2 Japan Anti-Tumor Drugs Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Anti-Tumor Drugs Consumption by Regions
4.1 Global Anti-Tumor Drugs Consumption by Regions
4.2 North America Anti-Tumor Drugs Consumption (2014-2019)
4.3 Europe Anti-Tumor Drugs Consumption (2014-2019)
4.4 China Anti-Tumor Drugs Consumption (2014-2019)
4.5 Japan Anti-Tumor Drugs Consumption (2014-2019)

5 Global Anti-Tumor Drugs Production, Revenue, Price Trend by Type
5.1 Global Anti-Tumor Drugs Production Market Share by Type (2014-2019)
5.2 Global Anti-Tumor Drugs Revenue Market Share by Type (2014-2019)
5.3 Global Anti-Tumor Drugs Price by Type (2014-2019)
5.4 Global Anti-Tumor Drugs Production Growth by Type (2014-2019)

6 Global Anti-Tumor Drugs Market Analysis by Applications
6.1 Global Anti-Tumor Drugs Consumption Market Share by Application (2014-2019)
6.2 Global Anti-Tumor Drugs Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Anti-Tumor Drugs Business
7.1 Roche
7.1.1 Roche Anti-Tumor Drugs Production Sites and Area Served
7.1.2 Anti-Tumor Drugs Product Introduction, Application and Specification
7.1.3 Roche Anti-Tumor Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served
7.2 Novartis
7.2.1 Novartis Anti-Tumor Drugs Production Sites and Area Served
7.2.2 Anti-Tumor Drugs Product Introduction, Application and Specification
7.2.3 Novartis Anti-Tumor Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business and Markets Served
7.3 Celgene
7.3.1 Celgene Anti-Tumor Drugs Production Sites and Area Served
7.3.2 Anti-Tumor Drugs Product Introduction, Application and Specification
7.3.3 Celgene Anti-Tumor Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business and Markets Served

8 Anti-Tumor Drugs Manufacturing Cost Analysis
8.1 Anti-Tumor Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Anti-Tumor Drugs
8.4 Anti-Tumor Drugs Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.2 Anti-Tumor Drugs Distributors List
9.3 Anti-Tumor Drugs Customers

10 Market Dynamics
10.1 Market Trends
10.2 Opportunities
10.3 Market Drivers
10.4 Challenges
10.5 Influence Factors

11 Global Anti-Tumor Drugs Market Forecast
11.1 Global Anti-Tumor Drugs Production, Revenue Forecast
11.1.1 Global Anti-Tumor Drugs Production Growth Rate Forecast (2019-2025)
11.1.2 Global Anti-Tumor Drugs Revenue and Growth Rate Forecast (2019-2025)
11.1.3 Global Anti-Tumor Drugs Price and Trend Forecast (2019-2025)
11.2 Global Anti-Tumor Drugs Production Forecast by Regions (2019-2025)
11.2.1 North America Anti-Tumor Drugs Production, Revenue Forecast (2019-2025)
11.2.2 Europe Anti-Tumor Drugs Production, Revenue Forecast (2019-2025)
11.2.3 China Anti-Tumor Drugs Production, Revenue Forecast (2019-2025)
11.2.4 Japan Anti-Tumor Drugs Production, Revenue Forecast (2019-2025)
11.3 Global Anti-Tumor Drugs Consumption Forecast by Regions (2019-2025)
11.3.1 North America Anti-Tumor Drugs Consumption Forecast (2019-2025)
11.3.2 Europe Anti-Tumor Drugs Consumption Forecast (2019-2025)
11.3.3 China Anti-Tumor Drugs Consumption Forecast (2019-2025)
11.3.4 Japan Anti-Tumor Drugs Consumption Forecast (2019-2025)
11.4 Global Anti-Tumor Drugs Production, Revenue and Price Forecast by Type (2019-2025)
11.5 Global Anti-Tumor Drugs Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer